This document discusses a new device called Trustfusion that can assess the quality of stored blood non-invasively in 1-2 minutes. It summarizes that stored blood can deteriorate over time, leading to higher mortality rates in transfusions. Trustfusion consists of two modules - one that changes the direction of blood cell flow and another that measures light transmission to determine blood quality. Experts have provided positive feedback and it is cheaper and faster than competitors that have not reached the market yet. The business model involves providing devices to hospitals for a monthly fee per test. It forecasts sales of $0.76-1.95 million annually in the Russian market after completing development, certification and clinical trials.